Journey Medical Corp. (DERM)
8.04
-0.31
(-3.71%)
USD |
NASDAQ |
Feb 09, 16:00
8.08
+0.04
(+0.50%)
After-Hours: 20:00
Journey Medical EPS Diluted (Quarterly) : -0.0928 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Fortress Biotech, Inc. | 0.111 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.315M |
| Revenue (Quarterly) | 17.63M |
| Total Expenses (Quarterly) | 19.95M |
| Enterprise Value | 267.74M |
| Gross Profit Margin (Quarterly) | 61.32% |
| Profit Margin (Quarterly) | -13.13% |
| Earnings Yield | -4.57% |
| Normalized Earnings Yield | -4.567 |